CapWealth Advisors
ABBV icon

CapWealth Advisors’s AbbVie ABBV Stock Holding History

CapWealth Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$202K Sell
774
-25
-3% -$6.41K 0.02% 116
2026
Q2 		$201K Buy
+799
New +$172K 0.01% 113
2024
Q4 		– Sell
-1,262
Closed -$249K – 102
2024
Q3 		$249K Buy
1,262
+92
+8% +$17.2K 0.03% 99
2024
Q2 		$201K Buy
1,170
+1
+0.1% +$166 0.03% 97
2024
Q1 		$213K Sell
1,169
-1,658
-59% -$286K 0.02% 94
2023
Q4 		$438K Buy
2,827
+284
+11% +$41.4K 0.05% 70
2023
Q3 		$379K Sell
2,543
-340
-12% -$49.9K 0.05% 77
2023
Q2 		$388K Sell
2,883
-60
-2% -$8.8K 0.05% 78
2023
Q1 		$469K Sell
2,943
-99
-3% -$15.1K 0.06% 75
2022
Q4 		$492K Buy
3,042
+400
+15% +$61.3K 0.06% 80
2022
Q3 		$355K Sell
2,642
-308
-10% -$44.2K 0.05% 85
2022
Q2 		$452K Buy
2,950
+283
+11% +$43.2K 0.05% 84
2022
Q1 		$432K Hold
2,667
– – 0.04% 94
2021
Q4 		$361K Buy
+2,667
New +$315K 0.04% 98
2016
Q4 		– Sell
-1,545
Closed -$97K – 93
2016
Q3 		$97K Sell
1,545
-13
-0.8% -$842 0.02% 110
2016
Q2 		$96K Sell
1,558
-239
-13% -$14.6K 0.02% 111
2016
Q1 		$103K Buy
1,797
+639
+55% +$35.6K 0.03% 104
2015
Q4 		$69K Sell
1,158
-28
-2% -$1.61K 0.02% 114
2015
Q3 		$65K Sell
1,186
-100
-8% -$6.51K 0.02% 112
2015
Q2 		$86K Buy
1,286
+220
+21% +$14.4K 0.02% 108
2015
Q1 		$62K Buy
+1,066
New +$64.4K 0.01% 123
2014
Q4 		– Sell
-1,066
Closed -$62K – 89
2014
Q3 		$62K Hold
1,066
– – 0.01% 122
2014
Q2 		$60K Sell
1,066
-1,000
-48% -$52.5K 0.01% 130
2014
Q1 		$106K Hold
2,066
– – 0.03% 102
2013
Q4 		$109K Hold
2,066
– – 0.03% 108
2013
Q3 		$92K Hold
2,066
– – 0.03% 118
2013
Q2 		$85K Buy
+2,066
New +$90.4K 0.02% 122

Other funds holding ABBV

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Cardano Risk Management
Cardano Risk Management Rotterdam, Netherlands $18.2B AUM 38.97% 1-Year Est. Return
Sepio Capital
Sepio Capital Salt Lake City, Utah $2.5B AUM 20.77% 1-Year Est. Return
Hamlin Capital Management
Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Ferguson Wellman Capital Management
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return
ABN AMRO Investment Solutions
ABN AMRO Investment Solutions Paris Cedex 008 $13.2B AUM 30.55% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

CapWealth Advisors's ABBV Position: Q3 2026 in Review

CapWealth Advisors reduced its AbbVie (ABBV) stake by 3.1% in Q3 2026, selling an estimated $6.41K and leaving 774 shares worth $202K. The position accounts for 0.02% of the portfolio, ranked #116.

CapWealth Advisors first reported a position in ABBV in Q2 2013 and has held it in 27 quarters since. The position peaked at $492K in Q4 2022. 1,436 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • CapWealth Advisors held 774 shares of AbbVie worth $202K as of Q3 2026.
  • CapWealth Advisors sold 25 AbbVie shares in Q3 2026, an estimated $6.41K.
  • AbbVie made up 0.02% of CapWealth Advisors's portfolio in Q3 2026, its #116 holding.
  • CapWealth Advisors first reported a position in AbbVie in Q2 2013 and has held it in 27 quarters since.
  • CapWealth Advisors's AbbVie position peaked at $492K in Q4 2022.
  • 1,436 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on CapWealth Advisors's 13F filing for Q3 2026, filed 5 Oct 2026.